SCHEMBL28841108

SCHEMBL28841108

CC(=O)Nc1cc(-c2c[nH]nn2)cc(C(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR2E1 Q9Y466 1/20 0.46
▸ KDR P35968 5/20 0.42
▸ EGFR P00533 4/20 0.42
▸ FGFR1 P11362 3/20 0.42
▸ MAPT P10636 2/20 0.41
▸ KIF11 P52732 1/20 0.40
▸ GPR35 Q9HC97 1/20 0.39
▸ FYN P06241 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ RAF1 P04049 1/20 0.39
▸ IKBKE Q14164 1/20 0.38
▸ JUN P05412 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ AURKA O14965 1/20 0.37
▸ AURKB Q96GD4 1/20 0.37
▸ IKBKB O14920 1/20 0.37
▸ NSD2 O96028 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31144931 0.79 IKBKB (0.37) IKBKB
SCHEMBL5612710 0.76 MAPT (0.59) MAPTFYNRXFP1
SCHEMBL5773763 0.75 MAPT (0.67) NR2E1MAPTKIF11GPR35
SCHEMBL22276768 0.75 SMN1; SMN2 (0.56) MAPTRXFP1
SCHEMBL23328069 0.70 MAPT (0.59) NR2E1MAPTKIF11GPR35
SCHEMBL30977688 0.70 MAPT (0.54) NR2E1MAPTKIF11GPR35
SCHEMBL13483424 0.70 MAPT (0.59) NR2E1MAPTKIF11GPR35
SCHEMBL12144643 0.70 MAPT (0.54) NR2E1MAPTKIF11GPR35
SCHEMBL31729816 0.69 PSEN1 (0.68) NR2E1KDREGFRFGFR1
SCHEMBL17491415 0.69 BRAF (0.47) NR2E1KDREGFRFGFR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103896865-B 1,4-pentadiene-3-ketone compounds containing triazole amide and preparation method and application thereof 兴义民族师范学院 2017-03-22 — — CN disclosed
Send feedback